Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001415889-23-013038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $1.86 | +4,623 | 45.4K | +11% | +$8,599 |
| D | 2023-09-06 | 2023-09-05 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $17.53 | -400 | 44.9K | -0.9% | -$7,012 |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $17.76 | -1,241 | 43.7K | -3% | -$22.0K |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -4,623 | 7,492 | -38% | $0 |
| DM | 2023-09-06 | 2023-09-01 | KNSA | Paolini John F. | Chief MEDICAL Off | A - Grant | $0.00 | +45.5K | 6,496 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-09-05 | M | A | 400 | $1.86 | 45,292 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-09-01 | M | A | 2,498 | — | 44,408 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Common | Class A Common Share | 2023-09-05 | S | D | 400 | $17.53 | 44,892 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $17.56. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Common Share | 2023-09-02 | F | D | 507 | $17.76 | 44,892 | D | — | — | |
| 5 | Common | Class A Common Share | 2023-09-02 | M | A | 1,725 | — | 45,399 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 6 | Common | Class A Common Share | 2023-09-01 | F | D | 734 | $17.76 | 43,674 | D | — | — | |
| 7 | Derivative | Restricted Share Unit | 2023-09-02 | M | D | 1,725 | $0.00 | 3,450 | D | — · — to — | 1,725 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021. |
| 8 | Derivative | Share Option | 2023-09-05 | M | D | 400 | $0.00 | 139,817 | D | $1.86 · — to 2026-09-13 | 400 Class A Common Share | (F8) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2023-09-01 | A | A | 38,974 | $0.00 | 38,974 | D | $17.76 · — to 2033-08-31 | 38,974 Class A Common Share | (F6) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. |
| 10 | Derivative | Restricted Share Unit | 2023-09-01 | M | D | 2,498 | $0.00 | 7,492 | D | — · — to — | 2,498 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022. |
| 11 | Derivative | Restricted Share Unit | 2023-09-01 | A | A | 6,496 | $0.00 | 6,496 | D | — · — to — | 6,496 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023. (F6) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. |